Global Custom Peptide CDMO Services Supply, Demand and Key Producers, 2024-2030

Global Custom Peptide CDMO Services Supply, Demand and Key Producers, 2024-2030

Page: 143

Published Date: 13 Jun 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Custom Peptide CDMO (Contract Development and Manufacturing Organization) services refer to the outsourcing of peptide synthesis, development, and manufacturing processes to specialized companies. These services are provided by organizations with expertise in peptide chemistry, production, and quality control, helping pharmaceutical companies, biotech firms, and research institutions develop and produce peptides for various applications.

The global Custom Peptide CDMO Services market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Custom Peptide CDMO Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Custom Peptide CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Custom Peptide CDMO Services that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Custom Peptide CDMO Services total market, 2019-2030, (USD Million)
Global Custom Peptide CDMO Services total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Custom Peptide CDMO Services total market, key domestic companies, and share, (USD Million)
Global Custom Peptide CDMO Services revenue by player, revenue and market share 2019-2024, (USD Million)
Global Custom Peptide CDMO Services total market by Type, CAGR, 2019-2030, (USD Million)
Global Custom Peptide CDMO Services total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Custom Peptide CDMO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic, ScinoPharm, JPT, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Custom Peptide CDMO Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Custom Peptide CDMO Services Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Custom Peptide CDMO Services Market, Segmentation by Type
GMP Services
Non-GMP Services

Global Custom Peptide CDMO Services Market, Segmentation by Application:
Commercial
Scientific Research
Other

Companies Profiled:
Bachem
CordenPharma
PolyPeptide
AmbioPharm
Genscript
Thermo Fisher
USV Peptides
Bio Basic
ScinoPharm
JPT
CBL
Piramal Pharma
CPC Scientific
Creative Peptides
Chinese Peptide Company
ChengDu ShengNuo Biotec
AppTec Co., Ltd.
GL Biochem

Key Questions Answered
1. How big is the global Custom Peptide CDMO Services market?
2. What is the demand of the global Custom Peptide CDMO Services market?
3. What is the year over year growth of the global Custom Peptide CDMO Services market?
4. What is the total value of the global Custom Peptide CDMO Services market?
5. Who are the Major Players in the global Custom Peptide CDMO Services market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Custom Peptide CDMO Services Introduction
1.2 World Custom Peptide CDMO Services Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Custom Peptide CDMO Services Total Market by Region (by Headquarter Location)
1.3.1 World Custom Peptide CDMO Services Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Based Company Custom Peptide CDMO Services Revenue (2019-2030)
1.3.3 China Based Company Custom Peptide CDMO Services Revenue (2019-2030)
1.3.4 Europe Based Company Custom Peptide CDMO Services Revenue (2019-2030)
1.3.5 Japan Based Company Custom Peptide CDMO Services Revenue (2019-2030)
1.3.6 South Korea Based Company Custom Peptide CDMO Services Revenue (2019-2030)
1.3.7 ASEAN Based Company Custom Peptide CDMO Services Revenue (2019-2030)
1.3.8 India Based Company Custom Peptide CDMO Services Revenue (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Custom Peptide CDMO Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends

2 Demand Summary
2.1 World Custom Peptide CDMO Services Consumption Value (2019-2030)
2.2 World Custom Peptide CDMO Services Consumption Value by Region
2.2.1 World Custom Peptide CDMO Services Consumption Value by Region (2019-2024)
2.2.2 World Custom Peptide CDMO Services Consumption Value Forecast by Region (2025-2030)
2.3 United States Custom Peptide CDMO Services Consumption Value (2019-2030)
2.4 China Custom Peptide CDMO Services Consumption Value (2019-2030)
2.5 Europe Custom Peptide CDMO Services Consumption Value (2019-2030)
2.6 Japan Custom Peptide CDMO Services Consumption Value (2019-2030)
2.7 South Korea Custom Peptide CDMO Services Consumption Value (2019-2030)
2.8 ASEAN Custom Peptide CDMO Services Consumption Value (2019-2030)
2.9 India Custom Peptide CDMO Services Consumption Value (2019-2030)

3 World Custom Peptide CDMO Services Companies Competitive Analysis
3.1 World Custom Peptide CDMO Services Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Custom Peptide CDMO Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Custom Peptide CDMO Services in 2023
3.2.3 Global Concentration Ratios (CR8) for Custom Peptide CDMO Services in 2023
3.3 Custom Peptide CDMO Services Company Evaluation Quadrant
3.4 Custom Peptide CDMO Services Market: Overall Company Footprint Analysis
3.4.1 Custom Peptide CDMO Services Market: Region Footprint
3.4.2 Custom Peptide CDMO Services Market: Company Product Type Footprint
3.4.3 Custom Peptide CDMO Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
4.1 United States VS China: Custom Peptide CDMO Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Custom Peptide CDMO Services Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Custom Peptide CDMO Services Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Custom Peptide CDMO Services Consumption Value Comparison
4.2.1 United States VS China: Custom Peptide CDMO Services Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Custom Peptide CDMO Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Custom Peptide CDMO Services Companies and Market Share, 2019-2024
4.3.1 United States Based Custom Peptide CDMO Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Custom Peptide CDMO Services Revenue, (2019-2024)
4.4 China Based Companies Custom Peptide CDMO Services Revenue and Market Share, 2019-2024
4.4.1 China Based Custom Peptide CDMO Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Custom Peptide CDMO Services Revenue, (2019-2024)
4.5 Rest of World Based Custom Peptide CDMO Services Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Custom Peptide CDMO Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Custom Peptide CDMO Services Revenue (2019-2024)

5 Market Analysis by Type
5.1 World Custom Peptide CDMO Services Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 GMP Services
5.2.2 Non-GMP Services
5.3 Market Segment by Type
5.3.1 World Custom Peptide CDMO Services Market Size by Type (2019-2024)
5.3.2 World Custom Peptide CDMO Services Market Size by Type (2025-2030)
5.3.3 World Custom Peptide CDMO Services Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
6.1 World Custom Peptide CDMO Services Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Commercial
6.2.2 Scientific Research
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Custom Peptide CDMO Services Market Size by Application (2019-2024)
6.3.2 World Custom Peptide CDMO Services Market Size by Application (2025-2030)
6.3.3 World Custom Peptide CDMO Services Market Size Market Share by Application (2019-2030)

7 Company Profiles
7.1 Bachem
7.1.1 Bachem Details
7.1.2 Bachem Major Business
7.1.3 Bachem Custom Peptide CDMO Services Product and Services
7.1.4 Bachem Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Bachem Recent Developments/Updates
7.1.6 Bachem Competitive Strengths & Weaknesses
7.2 CordenPharma
7.2.1 CordenPharma Details
7.2.2 CordenPharma Major Business
7.2.3 CordenPharma Custom Peptide CDMO Services Product and Services
7.2.4 CordenPharma Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 CordenPharma Recent Developments/Updates
7.2.6 CordenPharma Competitive Strengths & Weaknesses
7.3 PolyPeptide
7.3.1 PolyPeptide Details
7.3.2 PolyPeptide Major Business
7.3.3 PolyPeptide Custom Peptide CDMO Services Product and Services
7.3.4 PolyPeptide Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 PolyPeptide Recent Developments/Updates
7.3.6 PolyPeptide Competitive Strengths & Weaknesses
7.4 AmbioPharm
7.4.1 AmbioPharm Details
7.4.2 AmbioPharm Major Business
7.4.3 AmbioPharm Custom Peptide CDMO Services Product and Services
7.4.4 AmbioPharm Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 AmbioPharm Recent Developments/Updates
7.4.6 AmbioPharm Competitive Strengths & Weaknesses
7.5 Genscript
7.5.1 Genscript Details
7.5.2 Genscript Major Business
7.5.3 Genscript Custom Peptide CDMO Services Product and Services
7.5.4 Genscript Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Genscript Recent Developments/Updates
7.5.6 Genscript Competitive Strengths & Weaknesses
7.6 Thermo Fisher
7.6.1 Thermo Fisher Details
7.6.2 Thermo Fisher Major Business
7.6.3 Thermo Fisher Custom Peptide CDMO Services Product and Services
7.6.4 Thermo Fisher Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Thermo Fisher Recent Developments/Updates
7.6.6 Thermo Fisher Competitive Strengths & Weaknesses
7.7 USV Peptides
7.7.1 USV Peptides Details
7.7.2 USV Peptides Major Business
7.7.3 USV Peptides Custom Peptide CDMO Services Product and Services
7.7.4 USV Peptides Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 USV Peptides Recent Developments/Updates
7.7.6 USV Peptides Competitive Strengths & Weaknesses
7.8 Bio Basic
7.8.1 Bio Basic Details
7.8.2 Bio Basic Major Business
7.8.3 Bio Basic Custom Peptide CDMO Services Product and Services
7.8.4 Bio Basic Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Bio Basic Recent Developments/Updates
7.8.6 Bio Basic Competitive Strengths & Weaknesses
7.9 ScinoPharm
7.9.1 ScinoPharm Details
7.9.2 ScinoPharm Major Business
7.9.3 ScinoPharm Custom Peptide CDMO Services Product and Services
7.9.4 ScinoPharm Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 ScinoPharm Recent Developments/Updates
7.9.6 ScinoPharm Competitive Strengths & Weaknesses
7.10 JPT
7.10.1 JPT Details
7.10.2 JPT Major Business
7.10.3 JPT Custom Peptide CDMO Services Product and Services
7.10.4 JPT Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 JPT Recent Developments/Updates
7.10.6 JPT Competitive Strengths & Weaknesses
7.11 CBL
7.11.1 CBL Details
7.11.2 CBL Major Business
7.11.3 CBL Custom Peptide CDMO Services Product and Services
7.11.4 CBL Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 CBL Recent Developments/Updates
7.11.6 CBL Competitive Strengths & Weaknesses
7.12 Piramal Pharma
7.12.1 Piramal Pharma Details
7.12.2 Piramal Pharma Major Business
7.12.3 Piramal Pharma Custom Peptide CDMO Services Product and Services
7.12.4 Piramal Pharma Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Piramal Pharma Recent Developments/Updates
7.12.6 Piramal Pharma Competitive Strengths & Weaknesses
7.13 CPC Scientific
7.13.1 CPC Scientific Details
7.13.2 CPC Scientific Major Business
7.13.3 CPC Scientific Custom Peptide CDMO Services Product and Services
7.13.4 CPC Scientific Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 CPC Scientific Recent Developments/Updates
7.13.6 CPC Scientific Competitive Strengths & Weaknesses
7.14 Creative Peptides
7.14.1 Creative Peptides Details
7.14.2 Creative Peptides Major Business
7.14.3 Creative Peptides Custom Peptide CDMO Services Product and Services
7.14.4 Creative Peptides Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Creative Peptides Recent Developments/Updates
7.14.6 Creative Peptides Competitive Strengths & Weaknesses
7.15 Chinese Peptide Company
7.15.1 Chinese Peptide Company Details
7.15.2 Chinese Peptide Company Major Business
7.15.3 Chinese Peptide Company Custom Peptide CDMO Services Product and Services
7.15.4 Chinese Peptide Company Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Chinese Peptide Company Recent Developments/Updates
7.15.6 Chinese Peptide Company Competitive Strengths & Weaknesses
7.16 ChengDu ShengNuo Biotec
7.16.1 ChengDu ShengNuo Biotec Details
7.16.2 ChengDu ShengNuo Biotec Major Business
7.16.3 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product and Services
7.16.4 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 ChengDu ShengNuo Biotec Recent Developments/Updates
7.16.6 ChengDu ShengNuo Biotec Competitive Strengths & Weaknesses
7.17 AppTec Co., Ltd.
7.17.1 AppTec Co., Ltd. Details
7.17.2 AppTec Co., Ltd. Major Business
7.17.3 AppTec Co., Ltd. Custom Peptide CDMO Services Product and Services
7.17.4 AppTec Co., Ltd. Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 AppTec Co., Ltd. Recent Developments/Updates
7.17.6 AppTec Co., Ltd. Competitive Strengths & Weaknesses
7.18 GL Biochem
7.18.1 GL Biochem Details
7.18.2 GL Biochem Major Business
7.18.3 GL Biochem Custom Peptide CDMO Services Product and Services
7.18.4 GL Biochem Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 GL Biochem Recent Developments/Updates
7.18.6 GL Biochem Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Custom Peptide CDMO Services Industry Chain
8.2 Custom Peptide CDMO Services Upstream Analysis
8.3 Custom Peptide CDMO Services Midstream Analysis
8.4 Custom Peptide CDMO Services Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Custom Peptide CDMO Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Custom Peptide CDMO Services Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Custom Peptide CDMO Services Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Custom Peptide CDMO Services Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Custom Peptide CDMO Services Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Custom Peptide CDMO Services Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Custom Peptide CDMO Services Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Custom Peptide CDMO Services Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Custom Peptide CDMO Services Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Custom Peptide CDMO Services Players in 2023
Table 12. World Custom Peptide CDMO Services Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Custom Peptide CDMO Services Company Evaluation Quadrant
Table 14. Head Office of Key Custom Peptide CDMO Services Players
Table 15. Custom Peptide CDMO Services Market: Company Product Type Footprint
Table 16. Custom Peptide CDMO Services Market: Company Product Application Footprint
Table 17. Custom Peptide CDMO Services Mergers & Acquisitions Activity
Table 18. United States VS China Custom Peptide CDMO Services Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Custom Peptide CDMO Services Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Custom Peptide CDMO Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Custom Peptide CDMO Services Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Custom Peptide CDMO Services Revenue Market Share (2019-2024)
Table 23. China Based Custom Peptide CDMO Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Custom Peptide CDMO Services Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Custom Peptide CDMO Services Revenue Market Share (2019-2024)
Table 26. Rest of World Based Custom Peptide CDMO Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Custom Peptide CDMO Services Revenue (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Custom Peptide CDMO Services Revenue Market Share (2019-2024)
Table 29. World Custom Peptide CDMO Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Custom Peptide CDMO Services Market Size Value by Type (2019-2024) & (USD Million)
Table 31. World Custom Peptide CDMO Services Market Size by Type (2025-2030) & (USD Million)
Table 32. World Custom Peptide CDMO Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Custom Peptide CDMO Services Market Size by Application (2019-2024) & (USD Million)
Table 34. World Custom Peptide CDMO Services Market Size by Application (2025-2030) & (USD Million)
Table 35. Bachem Basic Information, Manufacturing Base and Competitors
Table 36. Bachem Major Business
Table 37. Bachem Custom Peptide CDMO Services Product and Services
Table 38. Bachem Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Bachem Recent Developments/Updates
Table 40. Bachem Competitive Strengths & Weaknesses
Table 41. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 42. CordenPharma Major Business
Table 43. CordenPharma Custom Peptide CDMO Services Product and Services
Table 44. CordenPharma Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. CordenPharma Recent Developments/Updates
Table 46. CordenPharma Competitive Strengths & Weaknesses
Table 47. PolyPeptide Basic Information, Manufacturing Base and Competitors
Table 48. PolyPeptide Major Business
Table 49. PolyPeptide Custom Peptide CDMO Services Product and Services
Table 50. PolyPeptide Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. PolyPeptide Recent Developments/Updates
Table 52. PolyPeptide Competitive Strengths & Weaknesses
Table 53. AmbioPharm Basic Information, Manufacturing Base and Competitors
Table 54. AmbioPharm Major Business
Table 55. AmbioPharm Custom Peptide CDMO Services Product and Services
Table 56. AmbioPharm Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. AmbioPharm Recent Developments/Updates
Table 58. AmbioPharm Competitive Strengths & Weaknesses
Table 59. Genscript Basic Information, Manufacturing Base and Competitors
Table 60. Genscript Major Business
Table 61. Genscript Custom Peptide CDMO Services Product and Services
Table 62. Genscript Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Genscript Recent Developments/Updates
Table 64. Genscript Competitive Strengths & Weaknesses
Table 65. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 66. Thermo Fisher Major Business
Table 67. Thermo Fisher Custom Peptide CDMO Services Product and Services
Table 68. Thermo Fisher Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Thermo Fisher Recent Developments/Updates
Table 70. Thermo Fisher Competitive Strengths & Weaknesses
Table 71. USV Peptides Basic Information, Manufacturing Base and Competitors
Table 72. USV Peptides Major Business
Table 73. USV Peptides Custom Peptide CDMO Services Product and Services
Table 74. USV Peptides Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. USV Peptides Recent Developments/Updates
Table 76. USV Peptides Competitive Strengths & Weaknesses
Table 77. Bio Basic Basic Information, Manufacturing Base and Competitors
Table 78. Bio Basic Major Business
Table 79. Bio Basic Custom Peptide CDMO Services Product and Services
Table 80. Bio Basic Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Bio Basic Recent Developments/Updates
Table 82. Bio Basic Competitive Strengths & Weaknesses
Table 83. ScinoPharm Basic Information, Manufacturing Base and Competitors
Table 84. ScinoPharm Major Business
Table 85. ScinoPharm Custom Peptide CDMO Services Product and Services
Table 86. ScinoPharm Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. ScinoPharm Recent Developments/Updates
Table 88. ScinoPharm Competitive Strengths & Weaknesses
Table 89. JPT Basic Information, Manufacturing Base and Competitors
Table 90. JPT Major Business
Table 91. JPT Custom Peptide CDMO Services Product and Services
Table 92. JPT Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. JPT Recent Developments/Updates
Table 94. JPT Competitive Strengths & Weaknesses
Table 95. CBL Basic Information, Manufacturing Base and Competitors
Table 96. CBL Major Business
Table 97. CBL Custom Peptide CDMO Services Product and Services
Table 98. CBL Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. CBL Recent Developments/Updates
Table 100. CBL Competitive Strengths & Weaknesses
Table 101. Piramal Pharma Basic Information, Manufacturing Base and Competitors
Table 102. Piramal Pharma Major Business
Table 103. Piramal Pharma Custom Peptide CDMO Services Product and Services
Table 104. Piramal Pharma Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Piramal Pharma Recent Developments/Updates
Table 106. Piramal Pharma Competitive Strengths & Weaknesses
Table 107. CPC Scientific Basic Information, Manufacturing Base and Competitors
Table 108. CPC Scientific Major Business
Table 109. CPC Scientific Custom Peptide CDMO Services Product and Services
Table 110. CPC Scientific Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. CPC Scientific Recent Developments/Updates
Table 112. CPC Scientific Competitive Strengths & Weaknesses
Table 113. Creative Peptides Basic Information, Manufacturing Base and Competitors
Table 114. Creative Peptides Major Business
Table 115. Creative Peptides Custom Peptide CDMO Services Product and Services
Table 116. Creative Peptides Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. Creative Peptides Recent Developments/Updates
Table 118. Creative Peptides Competitive Strengths & Weaknesses
Table 119. Chinese Peptide Company Basic Information, Manufacturing Base and Competitors
Table 120. Chinese Peptide Company Major Business
Table 121. Chinese Peptide Company Custom Peptide CDMO Services Product and Services
Table 122. Chinese Peptide Company Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. Chinese Peptide Company Recent Developments/Updates
Table 124. Chinese Peptide Company Competitive Strengths & Weaknesses
Table 125. ChengDu ShengNuo Biotec Basic Information, Manufacturing Base and Competitors
Table 126. ChengDu ShengNuo Biotec Major Business
Table 127. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product and Services
Table 128. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. ChengDu ShengNuo Biotec Recent Developments/Updates
Table 130. ChengDu ShengNuo Biotec Competitive Strengths & Weaknesses
Table 131. AppTec Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 132. AppTec Co., Ltd. Major Business
Table 133. AppTec Co., Ltd. Custom Peptide CDMO Services Product and Services
Table 134. AppTec Co., Ltd. Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. AppTec Co., Ltd. Recent Developments/Updates
Table 136. AppTec Co., Ltd. Competitive Strengths & Weaknesses
Table 137. GL Biochem Basic Information, Manufacturing Base and Competitors
Table 138. GL Biochem Major Business
Table 139. GL Biochem Custom Peptide CDMO Services Product and Services
Table 140. GL Biochem Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. GL Biochem Recent Developments/Updates
Table 142. GL Biochem Competitive Strengths & Weaknesses
Table 143. Global Key Players of Custom Peptide CDMO Services Upstream (Raw Materials)
Table 144. Global Custom Peptide CDMO Services Typical Customers


List of Figures
Figure 1. Custom Peptide CDMO Services Picture
Figure 2. World Custom Peptide CDMO Services Total Revenue: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Custom Peptide CDMO Services Total Revenue (2019-2030) & (USD Million)
Figure 4. World Custom Peptide CDMO Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Figure 5. World Custom Peptide CDMO Services Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Custom Peptide CDMO Services Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Custom Peptide CDMO Services Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Custom Peptide CDMO Services Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Custom Peptide CDMO Services Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Custom Peptide CDMO Services Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Custom Peptide CDMO Services Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Custom Peptide CDMO Services Revenue (2019-2030) & (USD Million)
Figure 13. Custom Peptide CDMO Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 16. World Custom Peptide CDMO Services Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 18. China Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 23. India Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Custom Peptide CDMO Services by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Custom Peptide CDMO Services Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Custom Peptide CDMO Services Markets in 2023
Figure 27. United States VS China: Custom Peptide CDMO Services Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Custom Peptide CDMO Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Custom Peptide CDMO Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Custom Peptide CDMO Services Market Size Market Share by Type in 2023
Figure 31. GMP Services
Figure 32. Non-GMP Services
Figure 33. World Custom Peptide CDMO Services Market Size Market Share by Type (2019-2030)
Figure 34. World Custom Peptide CDMO Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Custom Peptide CDMO Services Market Size Market Share by Application in 2023
Figure 36. Commercial
Figure 37. Scientific Research
Figure 38. Other
Figure 39. World Custom Peptide CDMO Services Market Size Market Share by Application (2019-2030)
Figure 40. Custom Peptide CDMO Services Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Bachem
CordenPharma
PolyPeptide
AmbioPharm
Genscript
Thermo Fisher
USV Peptides
Bio Basic
ScinoPharm
JPT
CBL
Piramal Pharma
CPC Scientific
Creative Peptides
Chinese Peptide Company
ChengDu ShengNuo Biotec
AppTec Co., Ltd.
GL Biochem
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Custom Peptide CDMO Services Supply, Demand and Key Producers, 2024-2030

Global Custom Peptide CDMO Services Supply, Demand and Key Producers, 2024-2030

Page: 143

Published Date: 13 Jun 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Custom Peptide CDMO (Contract Development and Manufacturing Organization) services refer to the outsourcing of peptide synthesis, development, and manufacturing processes to specialized companies. These services are provided by organizations with expertise in peptide chemistry, production, and quality control, helping pharmaceutical companies, biotech firms, and research institutions develop and produce peptides for various applications.

The global Custom Peptide CDMO Services market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Custom Peptide CDMO Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Custom Peptide CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Custom Peptide CDMO Services that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Custom Peptide CDMO Services total market, 2019-2030, (USD Million)
Global Custom Peptide CDMO Services total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Custom Peptide CDMO Services total market, key domestic companies, and share, (USD Million)
Global Custom Peptide CDMO Services revenue by player, revenue and market share 2019-2024, (USD Million)
Global Custom Peptide CDMO Services total market by Type, CAGR, 2019-2030, (USD Million)
Global Custom Peptide CDMO Services total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Custom Peptide CDMO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic, ScinoPharm, JPT, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Custom Peptide CDMO Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Custom Peptide CDMO Services Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Custom Peptide CDMO Services Market, Segmentation by Type
GMP Services
Non-GMP Services

Global Custom Peptide CDMO Services Market, Segmentation by Application:
Commercial
Scientific Research
Other

Companies Profiled:
Bachem
CordenPharma
PolyPeptide
AmbioPharm
Genscript
Thermo Fisher
USV Peptides
Bio Basic
ScinoPharm
JPT
CBL
Piramal Pharma
CPC Scientific
Creative Peptides
Chinese Peptide Company
ChengDu ShengNuo Biotec
AppTec Co., Ltd.
GL Biochem

Key Questions Answered
1. How big is the global Custom Peptide CDMO Services market?
2. What is the demand of the global Custom Peptide CDMO Services market?
3. What is the year over year growth of the global Custom Peptide CDMO Services market?
4. What is the total value of the global Custom Peptide CDMO Services market?
5. Who are the Major Players in the global Custom Peptide CDMO Services market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Custom Peptide CDMO Services Introduction
1.2 World Custom Peptide CDMO Services Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Custom Peptide CDMO Services Total Market by Region (by Headquarter Location)
1.3.1 World Custom Peptide CDMO Services Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Based Company Custom Peptide CDMO Services Revenue (2019-2030)
1.3.3 China Based Company Custom Peptide CDMO Services Revenue (2019-2030)
1.3.4 Europe Based Company Custom Peptide CDMO Services Revenue (2019-2030)
1.3.5 Japan Based Company Custom Peptide CDMO Services Revenue (2019-2030)
1.3.6 South Korea Based Company Custom Peptide CDMO Services Revenue (2019-2030)
1.3.7 ASEAN Based Company Custom Peptide CDMO Services Revenue (2019-2030)
1.3.8 India Based Company Custom Peptide CDMO Services Revenue (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Custom Peptide CDMO Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends

2 Demand Summary
2.1 World Custom Peptide CDMO Services Consumption Value (2019-2030)
2.2 World Custom Peptide CDMO Services Consumption Value by Region
2.2.1 World Custom Peptide CDMO Services Consumption Value by Region (2019-2024)
2.2.2 World Custom Peptide CDMO Services Consumption Value Forecast by Region (2025-2030)
2.3 United States Custom Peptide CDMO Services Consumption Value (2019-2030)
2.4 China Custom Peptide CDMO Services Consumption Value (2019-2030)
2.5 Europe Custom Peptide CDMO Services Consumption Value (2019-2030)
2.6 Japan Custom Peptide CDMO Services Consumption Value (2019-2030)
2.7 South Korea Custom Peptide CDMO Services Consumption Value (2019-2030)
2.8 ASEAN Custom Peptide CDMO Services Consumption Value (2019-2030)
2.9 India Custom Peptide CDMO Services Consumption Value (2019-2030)

3 World Custom Peptide CDMO Services Companies Competitive Analysis
3.1 World Custom Peptide CDMO Services Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Custom Peptide CDMO Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Custom Peptide CDMO Services in 2023
3.2.3 Global Concentration Ratios (CR8) for Custom Peptide CDMO Services in 2023
3.3 Custom Peptide CDMO Services Company Evaluation Quadrant
3.4 Custom Peptide CDMO Services Market: Overall Company Footprint Analysis
3.4.1 Custom Peptide CDMO Services Market: Region Footprint
3.4.2 Custom Peptide CDMO Services Market: Company Product Type Footprint
3.4.3 Custom Peptide CDMO Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
4.1 United States VS China: Custom Peptide CDMO Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Custom Peptide CDMO Services Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Custom Peptide CDMO Services Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Custom Peptide CDMO Services Consumption Value Comparison
4.2.1 United States VS China: Custom Peptide CDMO Services Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Custom Peptide CDMO Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Custom Peptide CDMO Services Companies and Market Share, 2019-2024
4.3.1 United States Based Custom Peptide CDMO Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Custom Peptide CDMO Services Revenue, (2019-2024)
4.4 China Based Companies Custom Peptide CDMO Services Revenue and Market Share, 2019-2024
4.4.1 China Based Custom Peptide CDMO Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Custom Peptide CDMO Services Revenue, (2019-2024)
4.5 Rest of World Based Custom Peptide CDMO Services Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Custom Peptide CDMO Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Custom Peptide CDMO Services Revenue (2019-2024)

5 Market Analysis by Type
5.1 World Custom Peptide CDMO Services Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 GMP Services
5.2.2 Non-GMP Services
5.3 Market Segment by Type
5.3.1 World Custom Peptide CDMO Services Market Size by Type (2019-2024)
5.3.2 World Custom Peptide CDMO Services Market Size by Type (2025-2030)
5.3.3 World Custom Peptide CDMO Services Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
6.1 World Custom Peptide CDMO Services Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Commercial
6.2.2 Scientific Research
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Custom Peptide CDMO Services Market Size by Application (2019-2024)
6.3.2 World Custom Peptide CDMO Services Market Size by Application (2025-2030)
6.3.3 World Custom Peptide CDMO Services Market Size Market Share by Application (2019-2030)

7 Company Profiles
7.1 Bachem
7.1.1 Bachem Details
7.1.2 Bachem Major Business
7.1.3 Bachem Custom Peptide CDMO Services Product and Services
7.1.4 Bachem Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Bachem Recent Developments/Updates
7.1.6 Bachem Competitive Strengths & Weaknesses
7.2 CordenPharma
7.2.1 CordenPharma Details
7.2.2 CordenPharma Major Business
7.2.3 CordenPharma Custom Peptide CDMO Services Product and Services
7.2.4 CordenPharma Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 CordenPharma Recent Developments/Updates
7.2.6 CordenPharma Competitive Strengths & Weaknesses
7.3 PolyPeptide
7.3.1 PolyPeptide Details
7.3.2 PolyPeptide Major Business
7.3.3 PolyPeptide Custom Peptide CDMO Services Product and Services
7.3.4 PolyPeptide Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 PolyPeptide Recent Developments/Updates
7.3.6 PolyPeptide Competitive Strengths & Weaknesses
7.4 AmbioPharm
7.4.1 AmbioPharm Details
7.4.2 AmbioPharm Major Business
7.4.3 AmbioPharm Custom Peptide CDMO Services Product and Services
7.4.4 AmbioPharm Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 AmbioPharm Recent Developments/Updates
7.4.6 AmbioPharm Competitive Strengths & Weaknesses
7.5 Genscript
7.5.1 Genscript Details
7.5.2 Genscript Major Business
7.5.3 Genscript Custom Peptide CDMO Services Product and Services
7.5.4 Genscript Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Genscript Recent Developments/Updates
7.5.6 Genscript Competitive Strengths & Weaknesses
7.6 Thermo Fisher
7.6.1 Thermo Fisher Details
7.6.2 Thermo Fisher Major Business
7.6.3 Thermo Fisher Custom Peptide CDMO Services Product and Services
7.6.4 Thermo Fisher Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Thermo Fisher Recent Developments/Updates
7.6.6 Thermo Fisher Competitive Strengths & Weaknesses
7.7 USV Peptides
7.7.1 USV Peptides Details
7.7.2 USV Peptides Major Business
7.7.3 USV Peptides Custom Peptide CDMO Services Product and Services
7.7.4 USV Peptides Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 USV Peptides Recent Developments/Updates
7.7.6 USV Peptides Competitive Strengths & Weaknesses
7.8 Bio Basic
7.8.1 Bio Basic Details
7.8.2 Bio Basic Major Business
7.8.3 Bio Basic Custom Peptide CDMO Services Product and Services
7.8.4 Bio Basic Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Bio Basic Recent Developments/Updates
7.8.6 Bio Basic Competitive Strengths & Weaknesses
7.9 ScinoPharm
7.9.1 ScinoPharm Details
7.9.2 ScinoPharm Major Business
7.9.3 ScinoPharm Custom Peptide CDMO Services Product and Services
7.9.4 ScinoPharm Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 ScinoPharm Recent Developments/Updates
7.9.6 ScinoPharm Competitive Strengths & Weaknesses
7.10 JPT
7.10.1 JPT Details
7.10.2 JPT Major Business
7.10.3 JPT Custom Peptide CDMO Services Product and Services
7.10.4 JPT Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 JPT Recent Developments/Updates
7.10.6 JPT Competitive Strengths & Weaknesses
7.11 CBL
7.11.1 CBL Details
7.11.2 CBL Major Business
7.11.3 CBL Custom Peptide CDMO Services Product and Services
7.11.4 CBL Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 CBL Recent Developments/Updates
7.11.6 CBL Competitive Strengths & Weaknesses
7.12 Piramal Pharma
7.12.1 Piramal Pharma Details
7.12.2 Piramal Pharma Major Business
7.12.3 Piramal Pharma Custom Peptide CDMO Services Product and Services
7.12.4 Piramal Pharma Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Piramal Pharma Recent Developments/Updates
7.12.6 Piramal Pharma Competitive Strengths & Weaknesses
7.13 CPC Scientific
7.13.1 CPC Scientific Details
7.13.2 CPC Scientific Major Business
7.13.3 CPC Scientific Custom Peptide CDMO Services Product and Services
7.13.4 CPC Scientific Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 CPC Scientific Recent Developments/Updates
7.13.6 CPC Scientific Competitive Strengths & Weaknesses
7.14 Creative Peptides
7.14.1 Creative Peptides Details
7.14.2 Creative Peptides Major Business
7.14.3 Creative Peptides Custom Peptide CDMO Services Product and Services
7.14.4 Creative Peptides Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Creative Peptides Recent Developments/Updates
7.14.6 Creative Peptides Competitive Strengths & Weaknesses
7.15 Chinese Peptide Company
7.15.1 Chinese Peptide Company Details
7.15.2 Chinese Peptide Company Major Business
7.15.3 Chinese Peptide Company Custom Peptide CDMO Services Product and Services
7.15.4 Chinese Peptide Company Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Chinese Peptide Company Recent Developments/Updates
7.15.6 Chinese Peptide Company Competitive Strengths & Weaknesses
7.16 ChengDu ShengNuo Biotec
7.16.1 ChengDu ShengNuo Biotec Details
7.16.2 ChengDu ShengNuo Biotec Major Business
7.16.3 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product and Services
7.16.4 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 ChengDu ShengNuo Biotec Recent Developments/Updates
7.16.6 ChengDu ShengNuo Biotec Competitive Strengths & Weaknesses
7.17 AppTec Co., Ltd.
7.17.1 AppTec Co., Ltd. Details
7.17.2 AppTec Co., Ltd. Major Business
7.17.3 AppTec Co., Ltd. Custom Peptide CDMO Services Product and Services
7.17.4 AppTec Co., Ltd. Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 AppTec Co., Ltd. Recent Developments/Updates
7.17.6 AppTec Co., Ltd. Competitive Strengths & Weaknesses
7.18 GL Biochem
7.18.1 GL Biochem Details
7.18.2 GL Biochem Major Business
7.18.3 GL Biochem Custom Peptide CDMO Services Product and Services
7.18.4 GL Biochem Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 GL Biochem Recent Developments/Updates
7.18.6 GL Biochem Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Custom Peptide CDMO Services Industry Chain
8.2 Custom Peptide CDMO Services Upstream Analysis
8.3 Custom Peptide CDMO Services Midstream Analysis
8.4 Custom Peptide CDMO Services Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Custom Peptide CDMO Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Custom Peptide CDMO Services Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Custom Peptide CDMO Services Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Custom Peptide CDMO Services Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Custom Peptide CDMO Services Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Custom Peptide CDMO Services Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Custom Peptide CDMO Services Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Custom Peptide CDMO Services Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Custom Peptide CDMO Services Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Custom Peptide CDMO Services Players in 2023
Table 12. World Custom Peptide CDMO Services Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Custom Peptide CDMO Services Company Evaluation Quadrant
Table 14. Head Office of Key Custom Peptide CDMO Services Players
Table 15. Custom Peptide CDMO Services Market: Company Product Type Footprint
Table 16. Custom Peptide CDMO Services Market: Company Product Application Footprint
Table 17. Custom Peptide CDMO Services Mergers & Acquisitions Activity
Table 18. United States VS China Custom Peptide CDMO Services Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Custom Peptide CDMO Services Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Custom Peptide CDMO Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Custom Peptide CDMO Services Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Custom Peptide CDMO Services Revenue Market Share (2019-2024)
Table 23. China Based Custom Peptide CDMO Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Custom Peptide CDMO Services Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Custom Peptide CDMO Services Revenue Market Share (2019-2024)
Table 26. Rest of World Based Custom Peptide CDMO Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Custom Peptide CDMO Services Revenue (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Custom Peptide CDMO Services Revenue Market Share (2019-2024)
Table 29. World Custom Peptide CDMO Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Custom Peptide CDMO Services Market Size Value by Type (2019-2024) & (USD Million)
Table 31. World Custom Peptide CDMO Services Market Size by Type (2025-2030) & (USD Million)
Table 32. World Custom Peptide CDMO Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Custom Peptide CDMO Services Market Size by Application (2019-2024) & (USD Million)
Table 34. World Custom Peptide CDMO Services Market Size by Application (2025-2030) & (USD Million)
Table 35. Bachem Basic Information, Manufacturing Base and Competitors
Table 36. Bachem Major Business
Table 37. Bachem Custom Peptide CDMO Services Product and Services
Table 38. Bachem Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Bachem Recent Developments/Updates
Table 40. Bachem Competitive Strengths & Weaknesses
Table 41. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 42. CordenPharma Major Business
Table 43. CordenPharma Custom Peptide CDMO Services Product and Services
Table 44. CordenPharma Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. CordenPharma Recent Developments/Updates
Table 46. CordenPharma Competitive Strengths & Weaknesses
Table 47. PolyPeptide Basic Information, Manufacturing Base and Competitors
Table 48. PolyPeptide Major Business
Table 49. PolyPeptide Custom Peptide CDMO Services Product and Services
Table 50. PolyPeptide Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. PolyPeptide Recent Developments/Updates
Table 52. PolyPeptide Competitive Strengths & Weaknesses
Table 53. AmbioPharm Basic Information, Manufacturing Base and Competitors
Table 54. AmbioPharm Major Business
Table 55. AmbioPharm Custom Peptide CDMO Services Product and Services
Table 56. AmbioPharm Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. AmbioPharm Recent Developments/Updates
Table 58. AmbioPharm Competitive Strengths & Weaknesses
Table 59. Genscript Basic Information, Manufacturing Base and Competitors
Table 60. Genscript Major Business
Table 61. Genscript Custom Peptide CDMO Services Product and Services
Table 62. Genscript Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Genscript Recent Developments/Updates
Table 64. Genscript Competitive Strengths & Weaknesses
Table 65. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 66. Thermo Fisher Major Business
Table 67. Thermo Fisher Custom Peptide CDMO Services Product and Services
Table 68. Thermo Fisher Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Thermo Fisher Recent Developments/Updates
Table 70. Thermo Fisher Competitive Strengths & Weaknesses
Table 71. USV Peptides Basic Information, Manufacturing Base and Competitors
Table 72. USV Peptides Major Business
Table 73. USV Peptides Custom Peptide CDMO Services Product and Services
Table 74. USV Peptides Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. USV Peptides Recent Developments/Updates
Table 76. USV Peptides Competitive Strengths & Weaknesses
Table 77. Bio Basic Basic Information, Manufacturing Base and Competitors
Table 78. Bio Basic Major Business
Table 79. Bio Basic Custom Peptide CDMO Services Product and Services
Table 80. Bio Basic Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Bio Basic Recent Developments/Updates
Table 82. Bio Basic Competitive Strengths & Weaknesses
Table 83. ScinoPharm Basic Information, Manufacturing Base and Competitors
Table 84. ScinoPharm Major Business
Table 85. ScinoPharm Custom Peptide CDMO Services Product and Services
Table 86. ScinoPharm Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. ScinoPharm Recent Developments/Updates
Table 88. ScinoPharm Competitive Strengths & Weaknesses
Table 89. JPT Basic Information, Manufacturing Base and Competitors
Table 90. JPT Major Business
Table 91. JPT Custom Peptide CDMO Services Product and Services
Table 92. JPT Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. JPT Recent Developments/Updates
Table 94. JPT Competitive Strengths & Weaknesses
Table 95. CBL Basic Information, Manufacturing Base and Competitors
Table 96. CBL Major Business
Table 97. CBL Custom Peptide CDMO Services Product and Services
Table 98. CBL Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. CBL Recent Developments/Updates
Table 100. CBL Competitive Strengths & Weaknesses
Table 101. Piramal Pharma Basic Information, Manufacturing Base and Competitors
Table 102. Piramal Pharma Major Business
Table 103. Piramal Pharma Custom Peptide CDMO Services Product and Services
Table 104. Piramal Pharma Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Piramal Pharma Recent Developments/Updates
Table 106. Piramal Pharma Competitive Strengths & Weaknesses
Table 107. CPC Scientific Basic Information, Manufacturing Base and Competitors
Table 108. CPC Scientific Major Business
Table 109. CPC Scientific Custom Peptide CDMO Services Product and Services
Table 110. CPC Scientific Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. CPC Scientific Recent Developments/Updates
Table 112. CPC Scientific Competitive Strengths & Weaknesses
Table 113. Creative Peptides Basic Information, Manufacturing Base and Competitors
Table 114. Creative Peptides Major Business
Table 115. Creative Peptides Custom Peptide CDMO Services Product and Services
Table 116. Creative Peptides Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. Creative Peptides Recent Developments/Updates
Table 118. Creative Peptides Competitive Strengths & Weaknesses
Table 119. Chinese Peptide Company Basic Information, Manufacturing Base and Competitors
Table 120. Chinese Peptide Company Major Business
Table 121. Chinese Peptide Company Custom Peptide CDMO Services Product and Services
Table 122. Chinese Peptide Company Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. Chinese Peptide Company Recent Developments/Updates
Table 124. Chinese Peptide Company Competitive Strengths & Weaknesses
Table 125. ChengDu ShengNuo Biotec Basic Information, Manufacturing Base and Competitors
Table 126. ChengDu ShengNuo Biotec Major Business
Table 127. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product and Services
Table 128. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. ChengDu ShengNuo Biotec Recent Developments/Updates
Table 130. ChengDu ShengNuo Biotec Competitive Strengths & Weaknesses
Table 131. AppTec Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 132. AppTec Co., Ltd. Major Business
Table 133. AppTec Co., Ltd. Custom Peptide CDMO Services Product and Services
Table 134. AppTec Co., Ltd. Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. AppTec Co., Ltd. Recent Developments/Updates
Table 136. AppTec Co., Ltd. Competitive Strengths & Weaknesses
Table 137. GL Biochem Basic Information, Manufacturing Base and Competitors
Table 138. GL Biochem Major Business
Table 139. GL Biochem Custom Peptide CDMO Services Product and Services
Table 140. GL Biochem Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. GL Biochem Recent Developments/Updates
Table 142. GL Biochem Competitive Strengths & Weaknesses
Table 143. Global Key Players of Custom Peptide CDMO Services Upstream (Raw Materials)
Table 144. Global Custom Peptide CDMO Services Typical Customers


List of Figures
Figure 1. Custom Peptide CDMO Services Picture
Figure 2. World Custom Peptide CDMO Services Total Revenue: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Custom Peptide CDMO Services Total Revenue (2019-2030) & (USD Million)
Figure 4. World Custom Peptide CDMO Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Figure 5. World Custom Peptide CDMO Services Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Custom Peptide CDMO Services Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Custom Peptide CDMO Services Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Custom Peptide CDMO Services Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Custom Peptide CDMO Services Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Custom Peptide CDMO Services Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Custom Peptide CDMO Services Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Custom Peptide CDMO Services Revenue (2019-2030) & (USD Million)
Figure 13. Custom Peptide CDMO Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 16. World Custom Peptide CDMO Services Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 18. China Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 23. India Custom Peptide CDMO Services Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Custom Peptide CDMO Services by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Custom Peptide CDMO Services Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Custom Peptide CDMO Services Markets in 2023
Figure 27. United States VS China: Custom Peptide CDMO Services Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Custom Peptide CDMO Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Custom Peptide CDMO Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Custom Peptide CDMO Services Market Size Market Share by Type in 2023
Figure 31. GMP Services
Figure 32. Non-GMP Services
Figure 33. World Custom Peptide CDMO Services Market Size Market Share by Type (2019-2030)
Figure 34. World Custom Peptide CDMO Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Custom Peptide CDMO Services Market Size Market Share by Application in 2023
Figure 36. Commercial
Figure 37. Scientific Research
Figure 38. Other
Figure 39. World Custom Peptide CDMO Services Market Size Market Share by Application (2019-2030)
Figure 40. Custom Peptide CDMO Services Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Bachem
CordenPharma
PolyPeptide
AmbioPharm
Genscript
Thermo Fisher
USV Peptides
Bio Basic
ScinoPharm
JPT
CBL
Piramal Pharma
CPC Scientific
Creative Peptides
Chinese Peptide Company
ChengDu ShengNuo Biotec
AppTec Co., Ltd.
GL Biochem
jiaGou

Add To Cart

gouMai

Buy Now